Correa A

No ORCID on file · 2 papers in corpus · active 2021-2022
2022
Human vaccines & immunotherapeutics ·doi:10.1080/21645515.2022.2078626

Among women aged 27-45 years, the quadrivalent human papillomavirus (qHPV; HPV6/11/16/18) vaccine was generally well tolerated, efficacious, and immunogenic in the placebo-controlled FUTURE III study (NCT00090220; n = 3253). The qHPV vaccin…

2021
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab086

Study questionDoes the expansion of genome-wide association studies (GWAS) to a broader range of ancestries improve the ability to identify and generalise variants associated with age at menarche (AAM) in European populations to a wider ran…